Erin Gull | IR |
A. J. Kazimi | CEO |
Marty Cearnal | Chief Commercial Officer |
Michael Bonner | CFO |
Andrew D'Silva | B. Riley FBR |
Thanks to everyone participating on today’s call as Cumberland Pharmaceuticals provides Second Quarter 2020 Financial Report and Company Update. Please note that this call is being recorded and will be archived on Cumberland's website for one week from today’s date. I would now like to introduce Erin Gull, who handles Corporate Relations for Cumberland. Erin?
Good afternoon, and I hope everyone is safe and well.